These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 5536051

  • 1. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H, Logemann G.
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy].
    Hippius H, Lange J.
    Arzneimittelforschung; 1970 Jul; 20(7):888-90. PubMed ID: 5536050
    [No Abstract] [Full Text] [Related]

  • 4. [Persisting extrapyramidal syndrome following neuroleptic therapy].
    Nehlil J.
    Rev Neurol (Paris); 1969 Apr; 120(4):270-1. PubMed ID: 5343622
    [No Abstract] [Full Text] [Related]

  • 5. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R, Bauer MP, Gruber M, Hampel G, Luxenburger O, Richartz M, Wenzel W.
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract] [Full Text] [Related]

  • 6. [Causes of persisting extrapyramidal hyperkinesis after prolonged administration of major tranquilizers].
    Degkwitz R.
    Act Nerv Super (Praha); 1967 Nov; 9(4):389-400. PubMed ID: 5612952
    [No Abstract] [Full Text] [Related]

  • 7. [Extrapyramidal hyperkineses following prior cerebral damage and long-term therapy using neuroleptics: ballistic syndrome, "hysteroid" attacks and hyopharyngeal syndrome with special reference to the clinical picture: misdiagnosis of the disorders as psychogenic and schizophrenic symptoms].
    Meyendorf R.
    Schweiz Arch Neurol Neurochir Psychiatr; 1969 Nov; 105(1):165-76. PubMed ID: 4903648
    [No Abstract] [Full Text] [Related]

  • 8. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A, Bartholini G, Gey KF, Jenni A.
    Schweiz Med Wochenschr; 1970 May 09; 100(19):797-804. PubMed ID: 4924275
    [No Abstract] [Full Text] [Related]

  • 9. [Drug-induced Parkinson's syndrome].
    Degkwitz R.
    Dtsch Med Wochenschr; 1972 Jun 02; 97(22):882. PubMed ID: 5032182
    [No Abstract] [Full Text] [Related]

  • 10. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O, Heller S.
    Dis Nerv Syst; 1971 Jun 02; 32(6):409-15. PubMed ID: 5570695
    [No Abstract] [Full Text] [Related]

  • 11. Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
    Knutsson E, Mårtensson A.
    Scand J Rehabil Med; 1974 Jun 02; 6(2):89-93. PubMed ID: 4837060
    [No Abstract] [Full Text] [Related]

  • 12. Parkinson's syndrome--modern therapy, known facts and unanswered questions.
    Albert E.
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Sep 02; 6(5):229-46. PubMed ID: 4604872
    [No Abstract] [Full Text] [Related]

  • 13. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa, Fleĭs EP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Sep 02; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract] [Full Text] [Related]

  • 14. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C, Merlis S.
    Am J Psychiatry; 1967 Jan 02; 123(7):886-9. PubMed ID: 6016862
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE, Ferel D, Wurmser P.
    Schweiz Med Wochenschr; 1970 May 09; 100(19):805-13. PubMed ID: 4924276
    [No Abstract] [Full Text] [Related]

  • 16. [Extrapyramidal motor disorders in children as a side effect of therapy with neuroleptics and the new antiemetic metoclopramide].
    Witzel K.
    Arch Kinderheilkd; 1968 Sep 09; 177(3):277-83. PubMed ID: 5716215
    [No Abstract] [Full Text] [Related]

  • 17. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun 17; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract] [Full Text] [Related]

  • 18. [Considerations on hyperkinesis caused by L-dopa: significance of the biochemical deficit and anatomical deficit].
    Pinelli P.
    Arch Psicol Neurol Psichiatr; 1970 Jun 17; 31(5):405-16. PubMed ID: 5502810
    [No Abstract] [Full Text] [Related]

  • 19. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D.
    Fortschr Med; 1974 Aug 08; 92(22):906-9. PubMed ID: 4153689
    [No Abstract] [Full Text] [Related]

  • 20. [Drug-induced Parkinson's syndrome with cycle-dependent hyperkineses following intake of the contraceptive "Gestakliman"].
    Jörg J.
    Nervenarzt; 1971 Jun 08; 42(6):325-9. PubMed ID: 4397217
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.